A pharmacophore model for PDE IV inhibitors

被引：10
|
作者：
Polymeropoulos, EE
Hofgen, N
机构：
[1] Department of Chemical Research, Corporate R and D, ASTA Medica Group, D-60314, Frankfurt
来源：
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS | 1997年 / 16卷 / 03期
关键词：
PDE IV Inhibitors; asthma; pharmacophore; rolipram analogs; xanthine analogs; nitraquazone analogs; GRID calculations; molecular modelling;
D O I：
10.1002/qsar.19970160307
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Based on conformational analysis and GRID-contour calculations we developed a common primary pharmacophore for rolipram analog, nitraquazone and xanthine derivative PDE IV inhibitors. In spite of the structural differences exhibited by the three substance classes we could provide evidence that they share common hydrogen bonding and lipophilic enzyme binding sites.
引用
收藏
页码：231 / 234
页数：4
相关论文
共 50 条
  • [21] A Three-Dimensional Pharmacophore Model for IMPDH Inhibitors
    Yang, Na
    Wang, Jian
    Li, Jian
    Wang, Qing-He
    Wang, Yu
    Cheng, Mao-Sheng
    CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (01) : 175 - 182
  • [22] Pharmacophore model of influenza neuraminidase inhibitors - a systematic review
    Gong, Jian-Zhi
    Liu, Yu
    Xu, Wen-Fang
    PHARMAZIE, 2009, 64 (10): : 627 - 632
  • [23] Study on pharmacophore model of Protox inhibitors by DISCO method
    Li, AX
    Wang, JL
    Miao, FM
    ACTA CHIMICA SINICA, 1999, 57 (11) : 1226 - 1232
  • [24] Proceedings of PRINCETON IV: PDE5 inhibitors and cardiac health symposium
    Rosen, Raymond C.
    Miner, Martin
    Burnett, Arthur L.
    Blaha, Michael J.
    Ganz, Peter
    Goldstein, Irwin
    Kim, Noel
    Kohler, Tobias
    Lue, Tom
    McVary, Kevin
    Mulhall, John
    Parish, Sharon J.
    Sadeghi-Nejad, Hossein
    Sadovsky, Richard
    Sharlip, Ira
    Kloner, Robert A.
    SEXUAL MEDICINE REVIEWS, 2024, 12 (04) : 681 - 709
  • [25] ANTIINFLAMMATORY ACTIVITY OF PHOSPHODIESTERASE (PDE)-IV INHIBITORS IN ACUTE AND CHRONIC MODELS OF INFLAMMATION
    SEKUT, L
    YARNALL, D
    STIMPSON, SA
    NOEL, LS
    BATEMANFITE, R
    CLARK, RL
    BRACKEEN, MF
    MENIUS, JA
    CONNOLLY, KM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 100 (01): : 126 - 132
  • [26] Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health
    Kloner, Robert A.
    Burnett, Arthur L.
    Miner, Martin
    Blaha, Michael J.
    Ganz, Peter
    Goldstein, Irwin
    Kim, Noel N.
    Kohler, Tobias
    Lue, Tom
    Mcvary, Kevin T.
    Mulhall, John P.
    Parish, Sharon J.
    Sadeghi-Nejad, Hossein
    Sadovsky, Richard
    Sharlip, Ira D.
    Rosen, Raymond C.
    JOURNAL OF SEXUAL MEDICINE, 2023, 21 (02): : 90 - 116
  • [27] Discovery of novel DPP IV inhibitors: application of pharmacophore-based virtual screening
    Jyoti Sharma
    Divya Yadav
    Sarvesh Paliwal
    Medicinal Chemistry Research, 2013, 22 : 558 - 572
  • [28] Discovery of DPP IV Inhibitors by Pharmacophore Modeling and QSAR Analysis followed by in silico Screening
    Al-masri, Ihab M.
    Mohammad, K. Mohammad
    Taha, Mutasem O.
    CHEMMEDCHEM, 2008, 3 (11) : 1763 - 1779
  • [29] Pharmacophore modeling and molecular docking studies of acridines as potential DPP-IV inhibitors
    Abu Khalaf, R.
    Jarekji, Z.
    Al-Qirim, T.
    Sabbah, D.
    Shattat, G.
    CANADIAN JOURNAL OF CHEMISTRY, 2015, 93 (07) : 721 - 729
  • [30] Discovery of novel DPP IV inhibitors: application of pharmacophore-based virtual screening
    Sharma, Jyoti
    Yadav, Divya
    Paliwal, Sarvesh
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (02) : 558 - 572
12345